BSE filing, NSE: JYOTHYLAB. Summary written from the filing by ALFA Finder's alert engine.
Jyothy Labs Ltd: key numbers
- Share price
- ₹174.58
- Market cap
- ₹6,411 Cr
- Revenue (annual)
- ₹2,944 Cr
- Net profit (annual)
- ₹333.2 Cr
- P/E (TTM)
- 22.6×Sector 38.3×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 14.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jyothy Labs Ltd
All →Jyothy Labs Promoter Buying (Off-Market)
Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.
Jyothy Labs Board Meeting Date
Jyothy Labs has scheduled its Board of Directors meeting for November 4, 2026. The agenda includes approval of un-audited financial results for Q1 and H1 2026.
Jyothy Labs Insurance Claim: ₹6.63 Cr
Jyothy Labs received a Rs. 6.63 Crore insurance claim settlement regarding a previously reported warehouse fire incident.
- Value
- ₹6.63 Cr
Jyothy Labs Credit Rating
CARE Ratings has reaffirmed Jyothy Labs Limited's 'CARE AA; Stable' rating for its long-term bank facilities. The rating applies to facilities totaling Rs. 250 crore.
- Value
- ₹250.0 Cr
Jyothy Labs Employee Stock Options
Jyothy Labs has granted 1,46,141 Restricted Stock Units (RSUs) to eligible employees under its RSU Plan 2023. These units vest over a period of up to four years.
Jyothy Labs Capital Structure Change
Nalanda India Equity Fund Limited acquired a 0.85% stake in Jyothy Laboratories Limited. The acquisition of 3,102,384 shares increases the fund's total holding to 7.61%.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date